These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 27903666)
1. Managing adult Fontan patients: where do we stand? Clift P; Celermajer D Eur Respir Rev; 2016 Dec; 25(142):438-450. PubMed ID: 27903666 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic impact of pulmonary vasodilators on single ventricle physiology. Castaldi B; Bordin G; Padalino M; Cuppini E; Vida V; Milanesi O Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 29193758 [TBL] [Abstract][Full Text] [Related]
3. The use of Macitentan in Fontan circulation: a case report. Demetriades P; Aziz A; Condliffe R; Bowater SE; Clift PF BMC Cardiovasc Disord; 2017 May; 17(1):131. PubMed ID: 28532389 [TBL] [Abstract][Full Text] [Related]
6. A congenitally "poor" pulmonary artery is a major reason for exclusion from Fontan operation. Nakazawa M; Park I; Yamada M; Nakanishi T; Momma K; Hoshino S; Takanashi Y; Imai Y Heart Vessels; 1996; 11(4):197-202. PubMed ID: 9119809 [TBL] [Abstract][Full Text] [Related]
7. Bosentan induces clinical and hemodynamic improvement in candidates for right-sided heart bypass surgery. Hirono K; Yoshimura N; Taguchi M; Watanabe K; Nakamura T; Ichida F; Miyawaki T J Thorac Cardiovasc Surg; 2010 Aug; 140(2):346-51. PubMed ID: 20434177 [TBL] [Abstract][Full Text] [Related]
8. Advances in paediatric pulmonary vascular disease associated with bronchopulmonary dysplasia. Rossor T; Greenough A Expert Rev Respir Med; 2015 Feb; 9(1):35-43. PubMed ID: 25426585 [TBL] [Abstract][Full Text] [Related]
12. Building the case for novel clinical trials in pulmonary arterial hypertension. Ryan JJ; Rich JD; Maron BA Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):114-23. PubMed ID: 25604559 [No Abstract] [Full Text] [Related]
13. Heartbeat: Biomarkers and pulmonary artery hypertension. Otto CM Heart; 2016 Mar; 102(5):333-4. PubMed ID: 26869632 [No Abstract] [Full Text] [Related]
14. Pulmonary hypertension-"state of the art" management in 2012. Saxena A Indian Heart J; 2012; 64(1):60-73. PubMed ID: 22572428 [TBL] [Abstract][Full Text] [Related]
15. The pulmonary vascular bed in patients with functionally univentricular physiology and a Fontan circulation. Krimly A; Jain CC; Egbe A; Alzahrani A; Al Najashi K; Albert-Brotons D; Veldtman GR Cardiol Young; 2021 Aug; 31(8):1241-1250. PubMed ID: 34378498 [TBL] [Abstract][Full Text] [Related]
17. Bidirectional cavopulmonary shunt with additional pulmonary blood flow: a failed or successful strategy? Gérelli S; Boulitrop C; Van Steenberghe M; Maldonado D; Bojan M; Raisky O; Sidi D; Vouhé PR Eur J Cardiothorac Surg; 2012 Sep; 42(3):513-9. PubMed ID: 22368190 [TBL] [Abstract][Full Text] [Related]
18. Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies. Beghetti M Heart; 2010 Jun; 96(12):911-6. PubMed ID: 20538665 [TBL] [Abstract][Full Text] [Related]
19. Inflammation in pulmonary artery hypertension. Sakuma M; Toyoda S; Inoue T; Node K Vascul Pharmacol; 2019; 118-119():106562. PubMed ID: 31112745 [No Abstract] [Full Text] [Related]
20. Monitoring pulmonary artery pressure in children undergoing the Fontan procedure. Vasdev S; Chauhan S; Talwar S; Pandey A; Kiran U Asian Cardiovasc Thorac Ann; 2013 Jun; 21(3):303-5. PubMed ID: 24570496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]